© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
September 21, 2020
Treatments for VTE in children fall short as they require frequent monitoring and include unpredictable food and drug interactions.
September 17, 2020
Post-discharge thromboprophylaxis is not necessary.
The rate of adverse events was higher in patients suffering from both deep vein thrombosis and pulmonary embolisms than it was in just patients with DVT.
August 27, 2020
Future studies are needed to develop and validate better risk assessment tools.
August 12, 2020
Guideline adoption could lead to more use of thrombolytic therapy.
August 07, 2020
The study paves the way for prospective multi-institutional randomized control trials to further re-enforce the safe use of direct oral anticoagulants in patients with obesity.
July 31, 2020
A discussion on how thromboembolism research and care could benefit from progression in diagnostics.
July 30, 2020
Patients with a mPAP of at least 19 mm Hg and pulmonary artery wedge pressure of 15 mm Hg or less had an adjusted hazard ratio for mortality of 1.71.
A new systematic review and meta-analysis challenges the notion that preventing VTE is associated reduced mortality risk.
July 24, 2020
New findings evidences the device commonly used treatment in patients with VTE—despite its association with potentially new DVT development or existing DVT propagation.